Suppression of Experimental Autoimmune Uveitis by Angiotensin II Type 1 Receptor Blocker Telmisartan
Investigative Ophthalmology and Visual Science - United States
doi 10.1167/iovs.08-2649
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2009
Authors
Publisher
Association for Research in Vision and Ophthalmology (ARVO)